Article

Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients

2024-04-04

Abstract excerpt

<h4>Background: </h4> and objective: Symptoms of most neurodegenerative diseases, including Parkinson’s disease (PD), usually do not occur until substantial neuronal loss occurs. This makes the process of early diagnosis very challenging. Hence, this research used variant call format (VCF) analysis to detect variants and novel genes that could be used as prognostic indicators in the early diagnosis of prodromal PD...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d77d61b9-b2db-5a8d-89e0-6e829326113c
DOI: 10.20944/preprints202404.0303.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) PatientsDOI 10.20944/preprints202404.0303.v1Read

Update of the MDS research criteria for prodromal Parkinson's diseaseSemantic proximity Read

Clinical progression and genetic pathways in body-first and brain-first Parkinson's disease.Semantic proximity Read

Individualized brain radiomics-based network tracks distinct subtypes and abnormal patterns in prodromal Parkinson’s diseaseSemantic proximity Read

Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.Semantic proximity Read

Elucidate biomarkers and the molecular pathways associated with genetic variants that contribute to the etiology of Parkinson's disease.Semantic proximity Read

<p class="MDPI13authornamesori1" style="margin-bottom: 12.0pt; mso-line-height-alt: 14.0pt;">Genetic Associations of Parkinson’s Disease Clinical, Pathological, and Data-driven SubtypesSemantic proximity Read

Blood transcriptomics reveals a Parkinson’s disease signature and heterogeneous prodromal molecular profiles in isolated RBDSemantic proximity Read

The value of non-motor features and genetic variants of Parkinson’s disease for clustering Lewy body diseasesSemantic proximity Read

Monogenic Parkinson’s Disease and the Impact of<i>APOE</i>E4: A Case-Control StudySemantic proximity Read

Genome-wide association study of Parkinson’s disease progression biomarkers in 12 longitudinal patients’ cohortsSemantic proximity Read

Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide levelSemantic proximity Read

Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease RiskSemantic proximity Read